Baudax Bio Inc. (BXRX) Fundamentals

Baudax Bio Inc is a Pharmaceutical company. The company develops and commercialize products for hospital and related acute care settings.
SHARE INFORMATION
Market Cap$ 1,892,144
Shares Outstanding554,881
Float553,281
Percent Float99.71%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 1,080,000
Latest Fiscal EPS$ -420.80
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date2022-09-28
Dividend Rate$ 16.00
Dividend Yield469.21%
Payment Cash-
HOLDERS
Institutions41
Institutional Holdings Date2023-01-31
Institutional Bought Previous 3 Months790,176
Institutional Holdings Percent7.1%
Institutional Sold Previous 3 Months229,230
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months1,200
Insider Holdings Percent3.3
Insider Sold Previous 3 Months-
Insider Shares Owned667,719
TRADING INFO
52 Week High$ 291.06
52 Week Low$ 1.55
52 Week High Change$ -98.70
21 Day Moving Average$ 3.2929
21 Day Extended Moving Average$ 3.2776
50 Day Moving Average$ 3.3871
50 Day Extended Moving Average$ 4.1424
200 Day Moving Average$ 18.6165
200 Day Extended Moving Average$ 76.2125
10 Day Average Volume641,191
20 Day Average Volume2,805,314
30 Day Average Volume3,145,378
50 Day Average Volume2,665,213
Alpha-0.154042
Beta1.5502
Standard Deviation0.258131
R20.130434
7 Day Price Change$ 0.46
7 Day Percent Change15.59%
21 Day Price Change$ -0.08
21 Day Percent Change-2.29%
30 Day Price Change$ 0.39
30 Day Percent Change12.91%
Month to Date Price Change$ 0.46
Month to Date Percent Change15.59%
Quarter to Date Price Change$ 0.23
Quarter to Date Percent Change7.23%
180 Day Price Change$ -25.22
180 Day Percent Change-88.09%
200 Day Price Change$ -24.64
200 Day Percent Change-87.85%
Year to Date Price Change$ 0.23
Year to Date Percent Change7.23%

Baudax Bio Inc. (BXRX) Key Ratios

PROFITABILITY
EBIT Margin-442.9%
EBITDA Margin-240.8%
Pre-Tax Profit Margin0.0%
Profit Margin Count-30.55%
Gross Margin-105.5%
Profit Margin TOT-30.55%
INCOME STATEMENTS
Revenue$ 959,000
Revenue Per Share$ 0.6216
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-0.10
Total Debt To Equity2.10
Int Coverage-33.70
Current Ratio0.50
Leverage Ratio-19.20
Quick Ratio0.30
Long Term Debt To Capital0.55
VALUATION MEASURES
PE Ratio0.00
Enterprise Value$ 4,264,558
Price to Sales5.4862
Price to Free Cash-0.10
PE High Last 5 Years0.00
Price To Book0.70
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book-0.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover1.20
Invoice Turnover0.60
Assets Turnover0.00
Return Assets-57.04
Return on Equity111.92
Return on Capital-134.53

Baudax Bio Inc. (BXRX) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorKPMG LLP
CEOGerri A. Henwood
Emplyoees80
Last AuditUE
CIK0001780097
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address490 Lapp Road
Malvern, PA 19355
Websitehttps://www.baudaxbio.com
Facsimile+1 484 395-2471
Telephone+1 484 395-2470
Email-
Your Recent History
NASDAQ
BXRX
Baudax Bio
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20230208 22:33:42